Literature DB >> 9089033

Irreversible ototoxicity associated with zalcitabine.

S Monte1, J D Fenwick, E F Monteiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9089033     DOI： 10.1258/0956462971919723

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


× No keyword cloud information.
  5 in total

1.  Hearing function in patients living with HIV/AIDS.

Authors:  Amneris E Luque; Mark S Orlando; U-Cheng Leong; Paul D Allen; Joseph J Guido; Hongmei Yang; Hulin Wu
Journal:  Ear Hear       Date:  2014 Nov-Dec       Impact factor: 3.570

2.  In vitro assessment of antiretroviral drugs demonstrates potential for ototoxicity.

Authors:  Pru Thein; Gilda M Kalinec; Channy Park; Federico Kalinec
Journal:  Hear Res       Date:  2014-01-31       Impact factor: 3.208

3.  Noise-induced hearing loss in mice treated with antiretroviral drugs.

Authors:  Devrim Bektas; Glen K Martin; Barden B Stagner; Brenda L Lonsbury-Martin
Journal:  Hear Res       Date:  2008-02-08       Impact factor: 3.208

4.  Highly active antiretroviral therapy: Does it Sound toxic?

Authors:  Katijah Khoza-Shangase
Journal:  J Pharm Bioallied Sci       Date:  2011-01

5.  Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.

Authors:  Evans L Sagwa; Nunurai Ruswa; Farai Mavhunga; Timothy Rennie; Hubert G M Leufkens; Aukje K Mantel-Teeuwisse
Journal:  BMC Pharmacol Toxicol       Date:  2015-12-10       Impact factor: 2.483
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.